Hobart Group Holdings is now part of Precision for Value, a Precision for Medicine company. Precision for Value supports the achievement of commercial excellence for global pharmaceutical and life sciences clients focused on integrated market access and outcomes. Our capabilities have now expanded to include health economics, outcomes research, advanced payer analytics, and promotional effectiveness support. For more information visit www.precisionforvalue.com.